$Most Followed Members$

[DewmBoom]

$BIEL: Pulse Shortwave Therapy in Cervical Osteoarthritis

Active Comparator: ActiPatch Group
Subjects in this group will receive an active pulsed shortwave therapy device to wear 24 hours a day for 4 weeks.
Device: ActiPatch
A Pulsed Shortwave Therapy Device
Other Name: pulsed shortwave therapy

Placebo Comparator: Control Group
Subjects in this group will take Etoricoxib 60mg, once daily for 4 weeks.
Drug: Etoricoxib 60 mg
nonsteroidal anti-inflammatory drug used as standard therapy
Other Name: analgesic

Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 200 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Efficacy/Safety Profile Of Pulsed Shortwave Therapy in Cervical Osteoarthritis: A Comparison Study Against Etoricoxib
Actual Study Start Date : May 1, 2018
Estimated Primary Completion Date : May 1, 2019
Estimated Study Completion Date : May 1, 2019

https://clinicaltrials.gov/ct2/show/NCT03542955